Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP, Chief Development Officer
-
Stock Symbol
-
KPTI on Nasdaq
Stuart Poulton - trading volume in the past year for Karyopharm Therapeutics Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
27.4K |
$17.3K |
$0.63 |
Mar 4, 2025 |
Direct |
|
|
| Stock Option (right to buy) |
9.17K |
|
|
Feb 28, 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.